Table 1 Associations between EMVI and clinical risk predictors in train cohort
Characteristics | EMVI (−) (N = 27) | EMVI (+) (N = 17) | p |
|---|---|---|---|
Age, mean ± SD, years | 66.11 ± 12.24 | 61.12 ± 13.89 | 0.211 |
Sex, N (%) | 0.638 | ||
Male | 22 (81.48) | 12 (70.59) | |
Female | 5 (18.52) | 5 (29.41) | |
BMI, mean ± SD, kg/m2 | 23.31 ± 2.88 | 21.84 ± 2.36 | 0.078 |
CEA | 0.195 | ||
≤ 5 ng/mL, N (%) | 22 (81.48) | 10 (58.82) | |
> 5 ng/mL, N (%) | 5 (18.52) | 7 (41.18) | |
CA19-9 | 0.870 | ||
≤ 34 U/mL, N (%) | 24 (88.89) | 14 (82.35) | |
> 34 U/mL, N (%) | 3 (11.11) | 3 (17.65) | |
Distance, mean ± SD, mm | 68.85 ± 25.62 | 81.18 ± 39.87 | 0.211 |
cT N (%) | 0.001 | ||
T1 | 1 (3.70) | 0 (0) | |
T2 | 7 (25.93) | 1 (5.88) | |
T3 | 17 (62.96) | 9 (52.94) | |
T4a | 2 (7.41) | 6 (35.29) | |
T4b | 0 (0) | 1 (5.88) | |
cN N (%) | 0.002 | ||
Negative | 23 (85.19) | 6 (35.29) | |
Positive | 4 (14.81) | 11 (64.71) | |
LN, median, N | 0 | 5 | < 0.001 |
MR-EMVI, N (%) | 0.126 | ||
Negative | 26 (96.30) | 13 (76.47) | |
Positive | 1 (3.70) | 4 (23.53) | |
MR-CRM, N (%)* | 0.675 | ||
Negative | 26 (96.30) | 15 (88.24) | |
Positive | 1 (3.70) | 2 (11.76) |